Changes for page Community Meetings

Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -48,123 +48,8 @@
48	48
49	49	(% border="1" style="margin-right:auto" %)
50	50	|=(% style="background-color: rgb(0, 50, 97); color: white; width: 82px;" %)Date|=(% style="background-color: rgb(0, 50, 97); color: white; width: 740px;" %)Discussion Topics|=(% style="background-color: rgb(0, 50, 97); color: white; width: 123px;" %)Attachments
51		-| | |
52		-| | |
53		-| | |
54		-| | |
55		-|(((
56		-2025-10-17
57		-)))|(((
58		-* RESIST-D (Psychiatric Neuroimaging) onboarding to the EBRAINS HDC/VRE - Professor [[Dara Canon  >>url:https://www.linkedin.com/in/dara-m-cannon-37837116/?originalSubdomain=ie]], [[Andrea Fernandes>>url:https://www.linkedin.com/in/andreferfer/?originalSubdomain=ie]] & [[Theodora Voulgari>>url:https://www.linkedin.com/in/theodora-voulgari-57b7891a3/?originalSubdomain=gr]] (University of Galway, Ireland)
59		-)))|
60		-|(((
61		-2025-09-19
62		-)))|(((
63		-* OWKIN AI diagnostics - Rodrigo Barnes
64		-* Partnership with Charité through [[mosaic>>url:https://www.mosaic-research.com/]]
65		-* VRE overview and demo – Michael Schirner
66		-)))|
67		-|(((
68		-2025-07-25
69		-)))|(((
70		-* Use Case PACS-VRE:  Routine clinical brain MRIs for Charité Outcomes Research Repository integration
71		-)))|
72		-|(((
73		-2025-07-11
74		-)))|(((
75		-* VRE onboarding revisited
76		-** Use terms and their legal underpinnings
77		-** Data Protection Impact Assessment template
78		-** Accessing VRE platform
79		-)))|
80		-|(((
81		-2025-06-13
82		-)))|(((
83		-* Presentation of [[ADLIN >>url:https://www.adlin-science.com/en]] solutions (data management from research to care) - [[Paul Rinaudo>>url:https://www.linkedin.com/in/paul-rinaudo/?originalSubdomain=fr]] (CEO ADLIN)
84		-)))|
85		-|(((
86		-2025-04-04
87		-)))|(((
88		-* GPU access via VRE
89		-)))|
90		-|(((
91		-2025-03-21
92		-)))|(((
93		-* VRE use case presentation of Charité Department for Operative, Preventive and Pediatric Dentistry - Data processing needs: archiving, transformation (into a 3D tomography) and storage/processing/analysis of 3D structures (porosity, geometry etc) ** **– Prof. Dr. Paul Zaslansky (Charité)
94		-)))|
95		-|(((
96		-2025-03-07
97		-)))|(((
98		-* GDPR compliant HDC/VRE - EBRAINS Service for Sensitive Data** **– Michael Schirner (Charité)
99		-)))|
100		-|(((
101		-2025-02-21
102		-)))|(((
103		-* VRE Use Case with PACS and RedCap Integration – Stefanie Seltmann (Charité)
104		-)))|
105		-|(((
106		-2025-02-07
107		-)))|(((
108		-* Demonstration of the VRE Auto Deployment pipeline – Marc Sacks (Charité)
109		-)))|
110		-|(((
111		-2024-12-13
112		-)))|(((
113		-* Oslo Service for Sensitive Data (TSD)  - Ainar Drews, University of Oslo, Norway
114		-* User experience VRE onboarding - Anastasios Polykarpos Athanasiadis, AMU France
115		-)))|
116		-|(((
117		-2024-11-15
118		-)))|(((
119		-* Joint Controller Agreements versus Standard Contractual Clauses (SCCs) for processing personal and health data in the VRE – Michael Schirner (BIH, Charité)
120		-)))|
121		-|(((
122		-2024-11-01
123		-)))|(((
124		-* Use Case Synthetic MRI data & Data Protection (Tanja Schmitz-Hübsch, Neuroscience Clinical Research CenterCharité)
125		-)))|
126		-|(((
127		-2024-10-18
128		-)))|(((
129		-* Transparency & Accountability in Cloud-Architectures (Dr. Ing. Elias Grünewald, Insitut für medizinische Informatik, Charité)
130		-)))|
131		-|(((
132		-2024-09-20
133		-)))|(((
134		-* LLMs to support clinical research (Loreen Ruhm, Johanna Nothacker, AG von Kalle, BIH-Charité)
135		-)))|
136		-|(((
137		-2024-09-06
138		-)))|(((
139		-* VRE Use Case:  Patient-orientated intensive care monitoring with Philips Data Warehouse Connect System (Anne Rike Flint, Charité)
140		-)))|
141		-|(((
142		-2024-06-28
143		-)))|(((
144		-* VRE Use Case ‘Chronic dynamics of electrophysiological biomarkers in dystonia patients with deep brain stimulation – a multi-center study’ - (Lucia Feldmann & Andrea Kühn, Charité)
145		-)))|
146		-|(((
147		-2024-05-17
148		-)))|(((
149		-* Presentation BASE4NFDI – Jana Tatscheck, Sandra Zaenkert
150		-* Presentation & demo VRE – Michael Schirner
151		-)))|
152		-|(((
153		-2024-04-19
154		-)))|(((
155		-* MedConnect Project - Martin Hoffmann & Jens Warfsmann (Fraunhofer ITEM)
156		-* VRE Onboardng Process – Michael Schirner (Charité)
157		-)))|
158		-|(((
159		-2024-04-05
160		-)))|(((
161		-* Use Case NFDI4Immuno [[https:~~/~~/www.nfdi4immuno.de/>>url:https://www.nfdi4immuno.de/]] (PD Dr. Cornelia Eckert, Charité)
162		-* Live demo VRE – Michael Schirner (Charité, Berlin)
163		-)))|
164	164	|2024-03-22|(((
165		-* Sharing experience in deploying the trusted VRE at the Sahlgrenska University Hospital in Sweden -  Petrus Åström and team (Sahlgrenska University Hospital and VGR, Sweden)
166		-
167		-* Routine data for neuroimaging studies in critically ill and vulnerable patient groups: delirium as a use case - Florian Lammers-Lietz(Charité, Berlin)
	52	+Sharing experience in deploying the trusted VRE at the Sahlgrenska University Hospital in Sweden -  Petrus Åström and team (Sahlgrenska University Hospital and VGR, Sweden)
168	168	)))|[[attach:2024-03-22_VRE-Community_Local-deployments.mp4||rel="noopener noreferrer" target="_blank"]]
169	169	|2023-09-08|VRE Demo - full functional scope ( Michael Schirner & Patrik Bey)|
170	170	|2023-07-14|VRE Demo + Development Update ( VRE Team ) & Use Case presentation ( Katrin Hahn ) & AlmaHealthDB ( Sabato Mellone with Marco Viceconti )|